You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »
 

CodeSizePriceAbpointsAvailability
    
 
  • -
  •   
  •   
  •   
  •  
  •   
  •   
Updating...

Overview

Product name

Anti-FH antibody
See all FH products (7) ...

Description

Mouse monoclonal to FH

Tested applications

WBmore details

Cross reactivity

Reacts with

Human

Immunogen

Recombinant full length protein, corresponding to amino acids 33-511 of Human FH

Properties

Form

Liquid

Storage instructions

Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Storage buffer

Preservative: None
PBS, pH 7.2

Concentration

Concentration information loading...

Purity

Protein G purified

Clonality

Monoclonal

Isotype

IgG2a

Light chain type

kappa

  • Western blot - FH antibody (ab58232)Western blot - FH antibody (ab58232) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab58232 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

WB: Use at a concentration of 1-5 µg/ml.


Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Function

Also acts as a tumor suppressor.

Pathway

Carbohydrate metabolism; tricarboxylic acid cycle; (S)-malate from fumarate: step 1/1.

Involvement in disease

Defects in FH are the cause of fumarase deficiency (FHD) [MIM:606812]; also known as fumaricaciduria. FHD is characterized by progressive encephalopathy, developmental delay, hypotonia, cerebral atrophy and lactic and pyruvic acidemia.
Defects in FH are the cause of multiple cutaneous and uterine leiomyomata (MCUL1) [MIM:150800]. MCUL1 is an autosomal dominant condition in which affected individuals develop benign smooth muscle tumors (leiomyomata) of the skin. Affected females also usually develop leiomyomata of the uterus (fibroids).
Defects in FH are the cause of hereditary leiomyomatosis and renal cell cancer (HLRCC) [MIM:605839].

Sequence similarities

Belongs to the class-II fumarase/aspartase family. Fumarase subfamily.

Cellular localization

Cytoplasm and Mitochondrion.

Target information above from: UniProt accessionP07954 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • FH antibody
  • Fumarase antibody
  • Fumarate hydratase mitochondrial antibody
  • Fumarate hydratase, mitochondrial antibody
  • FUMH_HUMAN antibody
  • HLRCC antibody
  • LRCC antibody
  • MCL antibody
  • MCUL 1 antibody
  • MCUL1 antibody
  • MS709 antibody
  • Multiple hereditary cutaneous leiomyomata antibody
see all

Anti-FH antibody images:

  Western blot - FH antibody (ab58232)

Western blot - FH antibody (ab58232)

FH antibody (ab58232) at 1ug/lane + HeLa cell lysate at 25ug/lane.

References for Anti-FH antibody (ab58232)

This product has been referenced in:

  • Yang Yet al. UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer. Cancer Genet Cytogenet 196:45-55 (2010).Read more (PubMed: 19963135) »
  • Kienhöfer Jet al. Association of mitochondrial antioxidant enzymes with mitochondrial DNA as integral nucleoid constituents. FASEB J : (2009).Read more (PubMed: 19228881) »

See all 2 publications for this product

Publishing research using ab58232? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"